NOTE: These medicines have been approved for use under a collaborative care agreement (CCA) for gender incongruence as per the masculinising and/or feminising prescribing guidelines – please refer to these guidelines for the approved indication(s). Where medicines have been approved as adjunct therapy, these indications are listed below under the individual entry for the medicines.
Please note some medicines may be prescribed for masculinising and/or feminising therapy and adjunct therapy.
Sussex Gender Service (SGS) via a Collaborative Care Agreement (CCA)
The Sussex Gender Service (SGS) pilot is a waiting-list initiative; a local centre to serve the needs of trans and non-binary people in Sussex.
The service follows the same service specification from NHS England as other gender service pilots, which is similar to the existing gender identity clinics.
The SGS work under a collaborative care agreement (CCA), which allows for the prescribing and titrating of medication and the associated phlebotomy to be undertaken at patients' GP surgery.
Sussex Gender Service :: Sussex Partnership NHS Foundation Trust
Sussex Gender Service (SGS) Guidance for GPs
Sussex Gender Service (SGS) Collaborative Care Agreement (CCA)
Please prescribe generically where possible
Approved as an adjunct therapy for hirsutism for gender dysphoria.
| Pack |
|---|
| 30 capsule |
| Pack |
|---|
| 30 capsule |
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
| Pack |
|---|
| 8 patch |
| Pack |
|---|
| 8 patch |
| Pack |
|---|
| 8 patch |
| Pack |
|---|
| 8 patch |
| Pack |
|---|
| 8 patch |
Approved as an adjunct therapy for menstrual suppression for gender dysphoria.
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
Approved as an adjunct therapy for menstrual suppression for gender dysphoria.
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
| Pack |
|---|
| 63 tablet (3 x 21 tablets) |
Approved as an adjunct therapy for menstrual suppression for gender dysphoria.
| Pack |
|---|
| 1 device |
| Pack |
|---|
| 8 patch |
| Pack |
|---|
| 8 patch |
| 24 patch |
| 4 patch |
| Pack |
|---|
| 8 patch |
| Pack |
|---|
| 8 patch |
Please prescribe generically where possible.
Approved as an adjunct therapy for hirsutism for gender dysphoria.
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 15 tablet |
| Pack |
|---|
| 28 tablet |
Approved as an adjunct therapy for menstrual suppression for gender dysphoria.
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 1 pre-filled disposable injection |
Approved as an adjunct therapy for menstrual suppression for gender dysphoria.
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 1 pre-filled disposable injection |
Approved as an adjunct therapy for menstrual suppression for gender dysphoria.
| Pack |
|---|
| 1 device |
| Pack |
|---|
| 1 device |
| Pack |
|---|
| 1 device |
| Pack |
|---|
| 1 device |
| Pack |
|---|
| 1 device |
Approved as an adjunct therapy for menstrual suppression for gender dysphoria.
| Pack |
|---|
| 30 tablet |
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
| Pack |
|---|
| 84 tablet (3 x 28 tablets) |
Approved as an adjunct therapy for menstrual suppression for gender dysphoria.
| Pack |
|---|
| 1 vial |
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 1 vial |
Gender-affirming hormone therapy for transgender females / non-binary patients assigned male at birth (Off-label)
| Pack |
|---|
| 56 dose |
| 168 dose (3 x 56 doses) |
Gender-affirming masculinising treatment for patients assigned female at birth (off-label use)
| Pack |
|---|
| 86 gram (1 x 85.5g with applicator) |
| 257 gram (3 x 85.5g with 1 applicator) |
| Pack |
|---|
| 88 gram |
| Pack |
|---|
| 30 sachet |
| Pack |
|---|
| 60 gram |
Treatment of vulvovaginal atrophy secondary to gender-affirming testosterone hormone therapy for patients assigned female at birth (off-label use)
| Pack |
|---|
| 30 gram |
| Pack |
|---|
| 80 gram |
| Pack |
|---|
| 1 pack (1 x (80g tube + 1 applicator)) |
| Pack |
|---|
| 15 pessary (3 x 5 pessaries) |
Treatment of vulvovaginal atrophy secondary to gender-affirming testosterone hormone therapy for patients assigned female at birth (off-label use)
| Pack |
|---|
| 24 pessary |
An adjunct to gender-affirming feminising hormone therapy for patients assigned male at birth
| Pack |
|---|
| 60 tablet (6 x 10 tablets) |
| Pack |
|---|
| 160 tablet (16 x 10 tablets) |
For the treatment of:
1) Adjunct for gender-affirming hormone therapy for transgender females / non-binary patientsassigned male at birth.
2) Adjunct for gender-affirming hormone therapy for transgender males / non-binary patientsassigned female at birth.
3) Gender-affirming menstrual suppression.
| Pack |
|---|
| 60 dose |
Adjunct for feminising gender-affirming hormone therapy for transgender females / non-binary patients assigned male at birth.
| Pack |
|---|
| 30 capsule |